SBIR/STTR Research Award
Predictive Analytics for Alzheimer s Disease Dementia
Award amount
$144,450Program and phase
SBIR · Phase IAward year
2017Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- APRIHEALTH, INC.
- Proposal award date
- 2017-09-15
- Contract end date
- 2018-08-31
- UEI
- Not reported
- Solicitation number
- PA16-302
- Topic code
- NIA
Research abstract
PROJECT SUMMARY
Increasing geriatric population and patients with multiple chronic conditions have exacerbated the
crisis of a rapid increase in number of Alzheimer s disease AD patients AD is the primary cause
of dementia and is responsible for over eleven million disability adjusted life years DALY
globally Overwhelming evidence indicates that progression of AD is associated with increased
dependency resource utilization and costs of care The diagnosis of AD and onset of dementia
not only places an emotional burden on patients but the costs associated with Alzheimer s care
also places substantial financial burden on families who often must make significant changes in
their economic lifestyles to extend care To mitigate the health emotional and financial burden
associated with AD we need to identify those at risk long before they develop symptoms of
dementia Early symptoms of dementia such as memory impairment may not be apparent during
the current practice of primary care visits unless directly assessed or adequately informed
Hence it is not surprising that many studies reveal delayed and or undocumented diagnosis of
dementia among primary care providers To address this critical unmet need we propose to use
machine learning and advanced predictive analytics and perform retrospective and prospective
analysis of data including clinical data from existing patient medical records financial data from
reimbursement claims and demographic data from population health records to identify clinical
co morbid pharmaceutical environmental and other variables related to onset and progression
of dementia The overarching goal of the present study is to develop a comprehensive decision
support tool that would predict cost drivers outcome measures and trajectory of dementia onset
in AD patients To achieve our goals we are working in collaboration with Chris Craver Senior
Director Health Data Analytics at Vizient Inc and Dr Ronald Petersen Director of Alzheimer s
Disease Research Center at Mayo Clinic Rochester We have now curated data from over
AD patients and age matched controls to date and are now proposing to pursue studies
with the following specific aims Aim Using descriptive analytics create an interactive secure
web based interface to enable benchmarking of key metrics for AD and AD dementia including
population health metrics co morbidities and risk factors therapeutic drug regimens and the true
costs of episodes of care Aim Develop an electronic health record EHR agnostic HIPAA
compliant tool for predicting the development of AD dementia its disease trajectory and
outcomes medication utilization total annual cost of care and any diagnostics or therapeutics to
augment adverse events Successful completion of studies proposed in this application would
enable physicians and care providers to better understand their AD patients with dementia
Additionally product developed through this grant study would benefit key stakeholders in
healthcare market place including Medicare Medicaid commercial insurers hospitals and health
systems in addition to AD patients and caregivers NARRATIVE
While Alzheimer s disease AD and aging have several common pathogenic events and
underlying risk factors diagnosis of AD not only affects the patient but also places enormous
emotional and financial burden on families and care providers There remains an urgent need to
reduce this burden by providing information in advance on the course of AD and costs associated
with care The work proposed in this application seek to address this problem by using advanced
analytics and machine learning techniques and identifying patients at risk of cognitive decline
and dementia By empowering physicians care providers insurers and health systems with
relevant patient information we will delineate trajectory of the disease and help refine the current
guidelines for dementia Our rationale for such a comprehensive approach is that by augmenting
clinical interventions and reducing inefficient resource consumption we will advance value based
care
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Evaluate the Safety, Tolerability, and Immunogenicity of Adjuvanted Preventive Dual Aβ/tau Vaccine, Duvax in Healthy Volunteers
- A Drug Discovery Platform to Prioritize Development of Natural Product Neuromodulators for Treating Cognitive Impairment
- VR-CARES: Feasibility of Virtual Reality for Caregiver Assembly, Relief, Empowerment, and Support to improve social connection, health, and at-home dementia care
- Developing an Integrated Brain State Monitor for Personalized Anesthesia Decision Support: Preventing Postoperative Delirium in Elderly and Patients At Risk for Alzheimer's or Related Dementias
- Lead Optimization of a Therapeutic Candidate for Alzheimer’s Disease